TMC Life Sciences Berhad (0101.KL)

MYR 0.49

(-1.01%)

Market Cap (In MYR)

853.52 Million

Revenue (In MYR)

346.41 Million

Net Income (In MYR)

40.64 Million

Avg. Volume

382.61 Thousand

Currency
MYR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.49-0.81
PE
-
EPS
-
Beta Value
0.664
ISIN
MYQ0101OO004
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Dr. Jun Li Heng
Employee Count
-
Website
https://www.tmclife.com
Ipo Date
2005-10-06
Details
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara (THKD), a 559-bedded medical center located in Selangor. Its THKD provides orthopedics, ENT, head and neck laser, women and children, fertility, dietetic, and accident and emergency services. The company's fertility center offers time lapse imaging, preimplantation genetic testing, fertility genecode, and other services. It also offers fertility consultancy services; laboratory and embryology; traditional and complementary; pharmacy services and products; and management support and multi-disciplinary tertiary care services. In addition, the company operates a women's clinic and fertility centers, as well as provides related services; develops, markets, and manages healthcare programs; and operates pharmacy store. Further, it engages in the research and development activities; and property investment activities. The company was founded in 1994 and is based in Petaling Jaya, Malaysia. TMC Life Sciences Berhad is a subsidiary of Sasteria (M) Pte. Ltd.